{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:11:52Z","timestamp":1760202712977},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0169","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T18:06:40Z","timestamp":1463422000000},"page":"1460-1469","source":"Crossref","is-referenced-by-count":8,"title":["Raison d\u2019etre of Tibial Artery Bypass for Intermittent Claudication in the Era of Endovascular Therapy"],"prefix":"10.1253","volume":"80","author":[{"given":"Shinsuke","family":"Mii","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Kyuragi","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Kyushu Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosei","family":"Kuma","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Fukuoka East Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Hidaka Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Masaki","sequence":"additional","affiliation":[{"name":"Masaki Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daihiko","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Fukuoka City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fukuoka Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Guntani","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Okadome","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases. <i>Eur Heart J<\/i> 2011; 32: 2851\u20132906.","DOI":"10.1093\/eurheartj\/ehr211"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). <i>J Am Coll Cardiol<\/i> 2011; 58: 2020\u20132045.","DOI":"10.1016\/j.jacc.2011.08.023"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gray BH, Diaz-Sandoval LJ, Dieter RS, Jaff MR, White CJ. SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use. <i>Catheter Cardiovasc Interv<\/i> 2014; 84: 539\u2013545.","DOI":"10.1002\/ccd.25395"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Conte SM, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, et al. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. <i>J Vasc Surg<\/i> 2015; 61: 1S\u201341S.","DOI":"10.1016\/j.jvs.2014.12.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Byrne J, Darling RC III, Chang BB, Paty PSK, Kreienberg PB, Lloyd WE, et al. Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures. <i>J Vasc Surg<\/i> 1999; 29: 259\u2013269.","DOI":"10.1016\/S0741-5214(99)70379-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA, Whittemore AD. Femorotibial bypass for claudication: Do results justify an aggressive approach? <i>J Vasc Surg<\/i> 1995; 21: 873\u2013880.","DOI":"10.1016\/S0741-5214(95)70214-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. <i>J Vasc Surg<\/i> 1997; 26: 517\u2013538.","DOI":"10.1016\/S0741-5214(97)70045-4"},{"key":"8","unstructured":"8. Mori A, Mii S, Eguchi D, Sakata H. Femoropopliteal bypass with externally supported knitted Dacron prosthesis: One to 18year follow-up. <i>Chirurgia<\/i> 2007; 20: 13\u201317."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Post S, Kraus T, Muller-Reinartz U, Weiss C, Kortmann H, Quentmeier A, et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: A prospective randomized multicentre trial. <i>Eur J Vasc Endovasc Surg<\/i> 2001; 22: 226\u2013231.","DOI":"10.1053\/ejvs.2001.1424"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Woratyla SP, Darling RC III, Chang BB, Paty PS, Kreinberg PB, Leather RP, et al. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee. <i>Am J Surg<\/i> 1997; 174: 169\u2013172.","DOI":"10.1016\/S0002-9610(97)90077-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pereira CE, Albers M, Romiti M, Brochado-Neto FC, Pereira CA. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. <i>J Vasc Surg<\/i> 2006; 44: 51\u201357.","DOI":"10.1016\/j.jvs.2006.04.054"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Menard MT, Belkin M. Infrapopliteal intervention for treatment of the claudicant. <i>Semin Vasc Surg<\/i> 2007; 20: 42\u201353.","DOI":"10.1053\/j.semvascsurg.2007.02.007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Arvela E, Venermo M, Soderstrom M, Alback A, Lepantalo M. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk. <i>Ann Vasc Surg<\/i> 2012; 26: 396\u2013403.","DOI":"10.1016\/j.avsg.2011.08.013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Avgerinos ED, Sachdev U, Naddaf A, Doucet DR, Mohapatra A, Leers SA, et al. Autologous alternative veins may not provide better outcomes than prosthetic conduits for below-knee bypass when great saphenous vein is unavailable. <i>J Vasc Surg<\/i> 2015; 62: 385\u2013391.","DOI":"10.1016\/j.jvs.2015.03.025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012): Digest version. <i>Circ J<\/i> 2014; 78: 2022\u20132093.","DOI":"10.1253\/circj.CJ-66-0094"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). <i>J Vasc Surg<\/i> 2007; 45(Suppl): S5\u2013S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Aihara H, Soga Y, Mii S, Okazaki J, Yamaoka T, Kamoi D, et al. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. <i>Circ J<\/i> 2014; 78: 457\u2013464.","DOI":"10.1253\/circj.CJ-13-1147"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Soga Y, Takahara M, Iida O, Mii S, Okazaki J, Nakano M, et al. Bypass surgery vs. drug-eluting stent for Trans-Atlantic Inter-Society Consensus II (TASC II) C or D femoropopliteal lesions. <i>Circ J<\/i> 2015; 79: 2688\u20132695.","DOI":"10.1253\/circj.CJ-15-0597"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. <i>J Am Coll Cardiol<\/i> 2012; 59: 16\u201323.","DOI":"10.1016\/j.jacc.2011.09.036"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yu W, Conte MS. Primary stenting in femoropopliteal occlusive disease: What is the appropriate role? <i>Circ J<\/i> 2015; 79: 704\u2013711.","DOI":"10.1253\/circj.CJ-15-0199"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Krankenberg H, Sorge I, Zeller T, Tubler T. Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: Acute and one-year results. <i>Catheter Cardiovasc Interv<\/i> 2005; 64: 12\u201317.","DOI":"10.1002\/ccd.20237"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: A double-blinded, multi-centre, randomized clinical trial. <i>Eur Heart J<\/i> 2011; 32: 2274\u20132281.","DOI":"10.1093\/eurheartj\/ehr144"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gasper WJ, Runge SJ, Owens CD. Management of infrapopliteal peripheral arterial occlusive disease. <i>Curr Treat Options Cardiovasc Med<\/i> 2012; 14: 136\u2013148.","DOI":"10.1007\/s11936-012-0164-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kamiya C, Sakamoto S, Tamori Y, Yoshimuta T, Higashi M, Tanaka R, et al. Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease. <i>Circ J<\/i> 2008; 72: 734\u2013739.","DOI":"10.1253\/circj.72.734"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/6\/80_CJ-16-0169\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T09:45:12Z","timestamp":1498297512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/6\/80_CJ-16-0169\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0169","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}